Dexcom Fair Value
DX
The fair market value of DXCM stock is 221.42 USD. Relative to the market price of 69.96 USD Dexcom is undervalued by 216.5%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Dexcom Valuation
Current DXCM share ticker price is 69.96 USD.
The fair value level of 221.42 USD can be considered as an effective entry point for long-term investors to start investing in DXCM stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 216% lower its fair value
Current price is 63% lower its minimum value
Current price is 374% lower its maximum value
Market price:
DXCM stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Dexcom Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
190.78
2
Median P/E over 5 years
127.27
3
Minimum P/E over 5 years
65.68
4
Earning per share (last 12 months)
1.74 USD
Maximum value
1
x
4
=
331.92 USD
Fair value
2
x
4
=
221.42 USD
Minimum value
3
x
4
=
114.27 USD
Dexcom Inc price metrics
12.18
Annual return (geometric mean)
52.19
Risk (standard deviation) of returns
β
1.1
Beta (volatility compared to market)